Home › Funds › Citadel Advisors › PHVS
Citadel Advisors position in PHVS
PHARVARIS N V · Health Care
Latest position (Q2 2026)250.38K sh
Reported value held$8.66M
Portfolio Weight0.00%
First reportedQ4 2023
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 141.46K | $3.97M | New |
| Q1 2024 | 238.31K | $5.51M | Add |
| Q2 2024 | 14.47K | $272.07K | Reduce |
| Q2 2025 | 29.22K | $514.29K | New |
| Q3 2025 | 129.74K | $3.24M | Add |
| Q4 2025 | 135.07K | $3.75M | Add |
| Q1 2026 | 168.63K | $4.76M | Add |
| Q2 2026 | 250.38K | $8.66M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PHVS
- Fidelity Management & Research (FMR) 6.57M sh · $227.03M · Q2 2026
- Viking Global Investors 3.65M sh · $126.33M · Q2 2026
- Wellington Management Group 2.39M sh · $82.75M · Q2 2026
- Point72 Asset Management 1.64M sh · $56.75M · Q2 2026
- BlackRock Inc 771.45K sh · $26.68M · Q2 2026
- Balyasny Asset Management 524.30K sh · $18.13M · Q2 2026
- D. E. Shaw & Co 471.40K sh · $16.30M · Q2 2026
- Millennium Management 427.40K sh · $14.78M · Q2 2026
- UBS Group AG 254.79K sh · $8.81M · Q2 2026
- Two Sigma Investments 216.64K sh · $7.49M · Q2 2026
- Goldman Sachs Group 149.98K sh · $5.19M · Q2 2026